Literature DB >> 393355

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

L J Kinlen, A G Sheil, J Peto, R Doll.   

Abstract

A collaborative study including centres in the United Kingdom, Australia, and New Zealand was instituted in 1970 to determine the incidence of cancer in patients treated for at least three months with azathioprine, cyclophosphamide, or chlorambucil. Follow-up of 3823 renal transplant recipients showed an almost 60-fold increase of non-Hodgkin's lymphoma together with an excess of squamous-cell skin cancer and mesenchymal tumours. A series of 1349 patients without transplants showed an excess of the same tumours, though to a less extent. These preliminary findings provide no clear evidence that immunosuppressive drugs produce the increased risk of most of the common cancers that might be expected from the simplest interpretation of impaired "immunosurveillance."

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393355      PMCID: PMC1597175          DOI: 10.1136/bmj.2.6203.1461

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  SOMATIC MUTATION AND CHRONIC DISEASE.

Authors:  M BURNET
Journal:  Br Med J       Date:  1965-02-06

2.  Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.

Authors:  E A Lipsmeyer
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

3.  Multiple sclerosis: reticulum cell sarcoma of the nervous system in a patient treated with immunosuppressive drugs.

Authors:  J Ulrich; R Wüthrich
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

4.  Immunosurveillance and cancer: epidemiological evidence.

Authors:  R Doll; L Kinlen
Journal:  Br Med J       Date:  1970-11-14

5.  Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.

Authors:  P B Doak; J Z Montgomerie; J D North; F Smith
Journal:  Br Med J       Date:  1968-12-21

6.  Transitional cell tumors of the renal pelvis in analgesic abusers.

Authors:  U Bengtsson; L Angervall; H Ekman; L Lehmann
Journal:  Scand J Urol Nephrol       Date:  1968

7.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

8.  Malignant lymphomas in transplantation patients.

Authors:  I Penn; W Hammond; L Brettschneider; T E Starzl
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

9.  Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.

Authors:  M C Gregory; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

10.  Skin cancer and immunosuppression.

Authors:  B K Walder; M R Robertson; D Jeremy
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

View more
  102 in total

1.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  Polyphenols: skin photoprotection and inhibition of photocarcinogenesis.

Authors:  F Afaq; S K Katiyar
Journal:  Mini Rev Med Chem       Date:  2011-12       Impact factor: 3.862

Review 3.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

4.  Skin cancer in an Irish renal transplant population.

Authors:  J F Bourke; G J Mellott; M Young; J Donohoe; M Carmody; J A Keogh
Journal:  Ir J Med Sci       Date:  1992-04       Impact factor: 1.568

5.  Meeting report. Report of meeting of Section of Clinical Immunology and Allergy, 11 March 1991.

Authors: 
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 5.344

6.  Quantification of Thiopurine/UVA-Induced Singlet Oxygen Production.

Authors:  Yazhou Zhang; Ashley N Barnes; Xianchun Zhu; Naomi F Campbell; Ruomei Gao
Journal:  J Photochem Photobiol A Chem       Date:  2011-10-15       Impact factor: 4.291

7.  Non-Hodgkin's lymphoma in rheumatoid arthritis.

Authors:  D Porter; R Madhok; H Capell
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

8.  IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Authors:  Maya Eisenring; Johannes vom Berg; Glen Kristiansen; Elisabeth Saller; Burkhard Becher
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

9.  Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia.

Authors:  H A Cubie; M Norval; L Crawford; L Banks; T Crook
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

Review 10.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.